<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD03160000_1</Organism_ID>
  <Organism>Rat</Organism>
  <Organism_Latin>Rattus norvegicus</Organism_Latin>
  <UniProt_ID>P33533</UniProt_ID>
  <Seq_Length>372</Seq_Length>
  <Molecule_Weight>40450</Molecule_Weight>
  <KEGG_ID>rno:24613</KEGG_ID>
  <Orthology_ID>K04213</Orthology_ID>
  <Function_Summary>Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Highly stereoselective. receptor for enkephalins.</Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>3</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>4</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>3</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>DOR-1</Alias>
      <Alias>Opioid receptor A</Alias>
      <Alias>D-OR-1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of calcium ions via a voltage-gated calcium channel.</Detail>
      <Keyword>Negative regulation of calcium ion transport via voltage-gated calcium channel activity</Keyword>
      <Ontology_ID>GO:0051927</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal.</Detail>
      <Keyword>Regulation of sensory perception of pain</Keyword>
      <Ontology_ID>GO:0051930</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand, followed by the activation of phospholipase C and the subsequent release of inositol trisphosphate.</Detail>
      <Keyword>Activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger</Keyword>
      <Ontology_ID>GO:0007200</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a growth factor stimulus.</Detail>
      <Keyword>Cellular response to growth factor stimulus</Keyword>
      <Ontology_ID>GO:0071363</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MEPVPSARAELQFSLLANVSDTFPSAFPSASANASGSPGARSASSLALAIAITALYSAVCAVGLLGNVLVMFGIVRYTKLKTATNIYIFNLALADALATSTLPFQSAKYLMETWPFGELLCKAVLSIDYYNMFTSIFTLTMMSVDRYIAVCHPVKALDFRTPAKAKLINICIWVLASGVGVPIMVMAVTQPRDGAVVCTLQFPSPSWYWDTVTKICVFLFAFVVPILIITVCYGLMLLRLRSVRLLSGSKEKDRSLRRITRMVLVVVGAFVVCWAPIHIFVIVWTLVDINRRDPLVVAALHLCIALGYANSSLNPVLYAFLDENFKRCFRQLCRAPCGGQEPGSLRRPRQATARERVTACTPSDGPGGGAAA</Protein_Seq>
    <DNA_Seq>GAGCGCTGCAGCCTGCGACGTCGGGGCCGTGGCCTCCGTTTTCCGCGCGCCACTCGCTGGGTCCCTGCGCCCAGGGCGCACGGTGGAGACGGACGCGGAGGCGCCATGGAGCCGGTGCCTTCTGCCCGTGCGGAGCTGCAGTTTTCGCTCCTCGCCAACGTCTCGGACACCTTCCCTAGCGCCTTCCCCAGTGCGAGCGCCAATGCGTCGGGGTCGCCGGGCGCCCGCAGTGCCTCGTCCCTGGCTCTGGCCATCGCCATCACCGCGCTCTACTCGGCTGTGTGCGCCGTGGGGCTGCTGGGCAACGTGCTCGTCATGTTTGGAATCGTCCGGTACACTAAGCTGAAGACGGCCACCAACATCTACATCTTCAATCTGGCCTTGGCGGATGCGCTGGCCACCAGCACACTGCCCTTCCAGAGCGCCAAGTACCTGATGGAAACGTGGCCGTTCGGAGAGCTGCTGTGCAAGGCTGTGCTCTCCATTGACTACTACAACATGTTCACCAGCATCTTCACGCTCACCATGATGAGCGTGGACCGCTACATTGCGGTCTGCCACCCTGTCAAGGCCTTGGACTTCCGGACACCGGCCAAGGCCAAGCTGATCAACATATGCATCTGGGTCTTGGCTTCAGGTGTTGGGGTCCCCATCATGGTCATGGCAGTGACCCAACCCCGGGATGGAGCAGTGGTATGCACGCTCCAGTTCCCCAGCCCCAGCTGGTACTGGGACACTGTGACCAAGATCTGCGTGTTCCTCTTCGCCTTCGTGGTGCCCATTCTCATCATCACCGTGTGCTATGGCCTCATGCTGCTGCGCCTGCGCAGCGTGCGCCTGCTGTCCGGCTCCAAGGAGAAGGACCGCAGCCTGCGGCGCATCACGCGCATGGTGCTGGTGGTGGTGGGAGCCTTCGTGGTGTGCTGGGCGCCCATCCACATCTTCGTCATCGTCTGGACGCTGGTGGACATCAATCGGCGCGACCCACTTGTGGTGGCCGCGCTGCACTTGTGCATTGCGCTGGGCTACGCCAACAGCAGCCTCAACCCGGTTCTCTACGCCTTCCTGGACGAGAACTTCAAGCGCTGCTTCCGCCAGCTCTGTCGCGCGCCCTGCGGCGGCCAAGAACCCGGCAGCCTCCGCCGTCCCCGCCAGGCCACCGCGCGTGAGCGTGTCACCGCCTGCACCCCCTCCGACGGCCCGGGCGGTGGCGCTGCCGCCTGACCTACCCGGCCCTCTGCTTAAACGCCCCACCCAAGTGAAGTGATGCAGTGGCCACACCGAGCTCCCTGGGAGGCCATGGCCACCATTGGGACAGCTAGAATAGGGCCCACACGGGGGGGGGGAGGCCTCCCATGAGGGCCGGGCCTGAGGAATCAAAGGCTCCGGGTTGGAGGGGTGGGGGTTGGGAGGGCAGA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Brain cortex</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>Oprd1</Gene_Name>
    <Gene_Alias>Ror-a</Gene_Alias>
    <Gene_ID>24613</Gene_ID>
    <Genbank_ACCN>NM_012617</Genbank_ACCN>
    <Protein_ACCN>NP_036749</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/24613</Gene_URL>
    <UCSC_ID>NM_012617</UCSC_ID>
    <EMBL_ID>ENSRNOG00000010531</EMBL_ID>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>Model of delta-type opioid receptor</PDB_Title>
      <PDB_ID>ASD03160000_1</PDB_ID>
      <Resolution>-1.0</Resolution>
      <Has_Ligand>No</Has_Ligand>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04080</Pathway_ID>
      <Pathway_Title>Neuroactive ligand-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04022</Pathway_ID>
      <Pathway_Title>cGMP-PKG signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
  </Network_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Rothman RB, et al.  Neuropeptides. 1984,4(3):201-215.</Site_Reference>
      <Site_Type>Two-site allosteric model</Site_Type>
      <PubMed_ID>6087189</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD01870242</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03160001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03160002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03160004</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03160005</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03160006</ASD_ID>
      <Modulator_Feature>Regulator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03160007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD03160008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09960001</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD09960002</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>